New hope for hard-to-treat BRAF cancers: drug targets tumor drivers
Disease control
Recruiting now
This study tests a drug called FORE8394 (plixorafenib) in people aged 10 and older whose cancers have specific BRAF gene changes. The goal is to see if the drug can shrink tumors or slow their growth. About 254 participants with advanced solid tumors or brain tumors will take the…
Phase: PHASE2 • Sponsor: Fore Biotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC